PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMC2 Therapeutics
MC2 Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
WynzoraBetamethasone, Calcipotriene2020-07-202027-2039
Psoriasis
,
Atopic dermatitis
,
Pruritus ani
,
Inflammation
,
Facial dermatoses
,
Seborrheic dermatitis
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Mycoses
,
Oral candidiasis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Cutaneous candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betamethasone
healthy volunteers/patients
Calcipotriene
psoriasis
Microcrystalline cellulose
acne vulgaris
,
actinic keratosis
,
keratosis
,
cataract
,
postoperative complications
,
eye infections
,
uveitis
,
inflammation
,
conjunctivitis
,
allergic conjunctivitis
,
contact lenses
Corticoids
sarcoidosis
,
pulmonary sarcoidosis
,
kidney transplantation
,
colitis
,
adrenal cortex neoplasms
,
adrenocortical carcinoma
,
diarrhea
,
asthma
,
endocrine system diseases
,
dwarfism
,
fetal growth retardation
,
juvenile arthritis
,
hiv infections
,
tuberculosis
,
acquired immunodeficiency syndrome
,
immune reconstitution inflammatory syndrome
,
multiple sclerosis
,
sclerosis
,
laron syndrome
,
chronic disease
,
arthritis
,
atopic dermatitis
,
eczema
,
dermatitis
,
syndrome
,
inflammation
,
rheumatic fever
,
multiple organ failure
,
glaucoma
,
open-angle glaucoma
,
ulcerative colitis
,
ulcer
Daivonex
psoriasis
,
coronary artery disease
,
myocardial ischemia
,
inflammation
,
atherosclerosis
Diprosone
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use